Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
426,231 results
  • Gastrointestinal tract metastasis presenting as intussusception in invasive lobular carcinoma of the breast: A case report. [Journal Article]
    Int J Surg Case Rep 2019; 64:109-112Mosiun JA, Idris MSB, … See MH
  • CONCLUSIONS: GI tract metastasis may present 30 years after the primary breast cancer. Up to 20% of patients may be asymptomatic as shown by Montagna et al. When present, symptoms are commonly non-specific and vague. Histological diagnosis is challenging. GI metastasis typically appears as intramural infiltration of the bowel wall by small cells arranged in cords.It is important to maintain a suspicion for GI tract metastasis in breast cancer patients who present with abdominal mass or GI symptoms, as this aids in prompt institution of accurate and appropriate management.
  • Immunologic tolerance of low-risk HPV in recurrent respiratory papillomatosis. [Review]
    Clin Exp Immunol 2019Ivancic R, Iqbal H, … Matrka L
  • Recurrent respiratory papillomatosis (RRP) is characterized by benign exophytic lesions of the respiratory tract caused by the human papillomavirus (HPV), in particular low-risk HPV6 and HPV11. Aggressiveness varies greatly among patients. Surgical excision is the current standard of care for RRP, with adjuvant therapy used when surgery cannot control disease recurrence. Numerous adjuvant therapi…
  • Exome sequencing of 22 genes using tissue from patients with biliary tract cancer. [Journal Article]
    APMIS 2019Høgdall D, Larsen OF, … Høgdall EV
  • CONCLUSIONS: Our panel is clinically validated and suitable for a high volume of samples to detect mutations in patients with BTC. However, it is reasonable to assume that the clinical utility could be optimized in this patient group by extending the panel to include BTC specific mutations with potential therapeutic consequences such as IDH1/2, FGFR-fusions, ERBB3 and BRCA1/2.
New Search Next